Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Palmitic acid
Price: Check
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

217082-60-5

217082-60-5 structure

217082-60-5 structure

Name: [Pyr1] -Apelin 13
Chemical Name: [Pyr1]-Apelin-13
CAS Number: 217082-60-5
Molecular Formula: C₆₉H₁₀₈N₂₂O₁₆S
Molecular Weight: 1533.8
Catalog: Biochemical Peptide
Create Date: 2018-08-05 20:30:26
Modify Date: 2026-07-23 17:23:57
[Pyr1]-Apelin-13 is a highly potent, selective endogenous apelin receptor (APJ) agonist.

Name	[Pyr1]-Apelin-13
Synonyms	pQRPRLSHKGPMPF [PYR1]-APELIN-13 [Pyr1]-Apelin-13,XRPRLSHKGPMPF,[pGlu1]-Apelin-13 3-Dimethyluric acid PYR-G-PRO-G-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE-OH //BP Deltorphin I (GLP1)-APELIN-13, HUMAN, BOVINE GLP-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE [PGLU1]APELIN , HUMAN, BOVINE (PYR1)-APELIN-13 (HUMAN, BOVINE, MOUSE, RAT) {Glp}-RPRLSHKGPMPF [Pyr1]-Apelin 13, endogenous apelin rector (APJ) agonist (Glp1)-Apelin-13 [PE]APELIN-13, HUMAN, BOVINE PYR-G-PRO-G-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE GLP-G-PRO-G-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE GLP-G-PRO-G-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE: PRLSHKGPMPF (Pyr)-Apelin-13 (human, bovine, mouse, rat) acetate salt PYR-G-PRO-G-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE-OH PYR-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE L-Phenylalanine, 5-oxo-L-prolyl-L-ginyl-L-prolyl-L-ginyl-L-leucyl-L-seryl-L-histidyl-L-lysylglycyl-L-prolyl-L-methionyl-L-prolyl Pyr-apelin-13 5-Oxo-L-prolyl-L-ginyl-L-prolyl-L-ginyl-L-leucyl-L-seryl-L-histidyl-L-lysylglycyl-L-prolyl-L-methionyl-L-prolyl-L-phenylalanine pyroglutamyl apelin-13 PGLU-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE PGLU-G-PRO-G-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE [pGlu1]-Apelin-13 PYR-RPRLSHKGPMPF-OH [Pyr1]-Apelin-13 trifluoroacetate salt 5-Oxo-L-prolyl-L-arginyl-L-prolyl-L-arginyl-L-leucyl-L-seryl-L-histidyl-L-lysylglycyl-L-prolyl-L-methionyl-L-prolyl-L-phenylalanine (PYR1)-APELIN-13 (HUMAN, BOVINE)

Description	[Pyr1]-Apelin-13 is a highly potent, selective endogenous apelin receptor (APJ) agonist.
Related Catalog	Signaling Pathways >> Others >> Others Peptides Research Areas >> Cardiovascular Disease
In Vitro	[Pyr1]-apelin-13 encapsulation in lipoPEG particles (lipoPEG-PA13) results in sustained and extended drug release under physiological conditions[1].
In Vivo	[Pyr1]-apelin-13 nanocarriers in a mouse model of pressure-overload induced heart failure demonstrate a sustainable long-term effect of [Pyr1]-apelin-13 in preventing cardiac dysfunction[1]. [Pyr1] apelin-13 (1, 5 μg) improves locomotor activity and reduces pain symptoms, cavity size and caspase-3 levels in rats. [Pyr1] apelin-13 (1, 5 μg) significantly increases thermal paw withdrawal latency. [Pyr1] apelin-13 in 5 μg dose also produces significant attenuation in paw withdrawal threshold compared to SCI animals from the second week post SCI[2].
References	[1]. Serpooshan V, et al. [Pyr1]-Apelin-13 delivery via nano-liposomal encapsulation attenuates pressure overload-induced cardiac dysfunction. Biomaterials. 2015 Jan;37:289-98. [2]. Hajimashhadi Z, et al. Chronic administration of [Pyr1] apelin-13 attenuates neuropathic pain after compression spinal cord injury in rats. Neuropeptides. 2017 Feb;61:15-22.

Density	1.5±0.1 g/cm3
Molecular Formula	C₆₉H₁₀₈N₂₂O₁₆S
Molecular Weight	1533.8
Exact Mass	1532.80343662
PSA	613.26000
LogP	-3.42
Index of Refraction	1.696
Storage condition	-15°C

29022-11-5 structure

29022-11-5

35661-60-0 structure

35661-60-0

71989-31-6 structure

71989-31-6

35661-40-6 structure

35661-40-6

71989-28-1 structure

71989-28-1

Detail

Literature: Zhang, Yanyan; Maitra, Rangan; Harris, Danni L.; Dhungana, Suraj; Snyder, Rodney; Runyon, Scott P. Bioorganic and Medicinal Chemistry, 2014 , vol. 22, # 11 p. 2992 - 2997

Precursor 7
29022-11-5 35661-60-0 71989-31-6 35661-40-6
71989-28-1 116611-64-4 98-79-3
DownStream 0

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.